| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 05/10/2002 | WO2002036160A2 Method for obtaining antigenic structures enhancing specific cross reactivity |
| 05/10/2002 | WO2002036143A1 Inhibition or reversal of skin aging by actin-sequestering peptides |
| 05/10/2002 | WO2002007676A3 Compounds having affinity for the granulocyte-colony stimulating factor receptor (g-csfr) |
| 05/10/2002 | WO2001077145A3 Integrin binding peptide derivatives |
| 05/10/2002 | WO2001074845A3 Immunogenic peptides derived from prostate-specific membrane antigen (psma) and uses thereof |
| 05/10/2002 | WO2001068677A3 Derivatives of breast canacer antigen her-2 for therapeutical use |
| 05/10/2002 | WO2001042423A3 Compositions and methods for detecting stress-inducible proteins |
| 05/10/2002 | WO2001036487A3 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/10/2002 | CA2428606A1 Novel targeted compositions for diagnostic and therapeutic use |
| 05/10/2002 | CA2427911A1 Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation |
| 05/10/2002 | CA2427539A1 Method for obtaining antigenic structures enhancing specific cross reactivity |
| 05/10/2002 | CA2426200A1 Inhibition or reversal of skin aging by actin-sequestering peptides |
| 05/09/2002 | US20020055614 Immune reactivity to her-2/neu protein for diagnosis and treatment of malignancies in which the her-2/neu oncogene is associated |
| 05/09/2002 | US20020055466 Terpolymer of tyrosine, alanine and lysine randomly polymerized into a polypeptide |
| 05/09/2002 | US20020055174 Complex for transferring an anionic substance of interest into a cell |
| 05/09/2002 | US20020054886 For treatment of disseminated candidiasis due to infection by C.albicans; monoclonal antibodies for use in passive immunization against candidal infections |
| 05/09/2002 | US20020054880 Suppressing inflammatory response in mammal by the administration of lectin derived carbohydrate binding peptide capable of binding terminally linked alpha-sialic acid derivative |
| 05/09/2002 | US20020054870 A peptide containing atleast 6 amino acid residues, having 70% homology with part or all of the sequence containing specific 14 amino acids |
| 05/09/2002 | US20020054855 Gastrin receptor-avid peptide conjugates |
| 05/08/2002 | EP1203591A1 Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| 05/08/2002 | EP1203026A1 Binding moieties for fibrin |
| 05/08/2002 | EP1203019A1 Peptides containing n-substituted l-amino acids for preventing beta-strand association |
| 05/08/2002 | EP1203017A1 Fab-EPITOPE COMPLEX FROM THE HIV-1 CROSS-NEUTRALIZING MONOCLONAL ANTIBODY 2F5 |
| 05/08/2002 | EP1203014A2 Peptide antagonists of factor viia |
| 05/08/2002 | EP1101113A4 Cell-signaling assays |
| 05/08/2002 | EP0998299A4 ISOLATED PEPTIDES WHICH COMPLEX WITH HLA-Cw*16 MOLECULES, AND USES THEREOF |
| 05/08/2002 | EP0789783B1 Antigen binding peptides (abtides) from peptide libraries |
| 05/08/2002 | EP0759933B1 Beta sheet forming peptides and gels made thereof |
| 05/08/2002 | CN1348492A Pseudomycin production by i(pseudomonas syringae) |
| 05/08/2002 | CN1348466A Epitopes or mimotopes derived from the c-epsilon-2-domain of IgE, antagonists thereof, and their therapeutic uses |
| 05/08/2002 | CN1348462A Novel LHRH-antagonists with improved solubility characteristics |
| 05/07/2002 | US6384218 Prepared by reacting amino acid, oligo- or polypeptide or polyamino acid with trialdehyde; molecular recognition agent for use in neurotransmission studies |
| 05/07/2002 | US6384190 Peptide of defined amino acid sequence which binds to human leukocyte antigen-a2 |
| 05/07/2002 | US6384188 Lipopolysaccharide-binding and neutralizing peptides |
| 05/07/2002 | US6384187 Administering microsclerodermin or salt to mammal as anticarcinogenic and antitumor agent |
| 05/07/2002 | US6384186 Cyclic dodecapeptide and process for the preparation thereof |
| 05/07/2002 | US6384014 Antibiotics as bactericides |
| 05/07/2002 | US6384013 Cyclic peptide antifungal agents and process for preparation thereof |
| 05/07/2002 | CA2190494C Heterodimer polypeptide immunogen carrier composition and method |
| 05/02/2002 | WO2002034915A2 Preferred segments of neural thread protein and methods of using the same |
| 05/02/2002 | WO2002034767A1 Vegf peptides and their use for inhibiting angiogenesis |
| 05/02/2002 | WO2002034288A2 Vaccine for treating allergy |
| 05/02/2002 | WO2002034283A2 Vegh inhibitors and their use |
| 05/02/2002 | WO2002034202A2 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 05/02/2002 | WO2001096368A3 Use of coiled-coil structural scaffold to generate structure-specific peptides |
| 05/02/2002 | WO2001060162A3 Cationic, amphipathic beta-sheet peptides and uses thereof |
| 05/02/2002 | WO2001038394A3 Polypetptides and methods for thymic vaccination |
| 05/02/2002 | WO2001036979A3 Placental human neurokinin b precursor |
| 05/02/2002 | US20020052469 Amino acid sequences for use in detection and treatment of viral infection |
| 05/02/2002 | US20020052323 Protease inhibitors, particularly for caspase enzyme; treating arthritis, ALS, MS, and the like. |
| 05/02/2002 | US20020052321 Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof |
| 05/02/2002 | US20020052315 Conformationally constrained backbone cyclized somatostatin analogs |
| 05/02/2002 | US20020052014 Peptide for use in detection of methylated proteins |
| 05/02/2002 | US20020051967 Retrovirus; for use as a tool in the diagnosis and prevention of viaral diseases |
| 05/02/2002 | US20020051819 Hexapeptide mixture with antimicrobial activity against Burkholderia cepacia and at least one carrier, effeactive for prevention of growth of Burkholderia cepacia for industrial, pharmeceutical, household and personal care use |
| 05/02/2002 | US20020051760 Method for screening a substance having promoting activity on hair growth |
| 05/02/2002 | EP1201676A2 PNA-DNA-PNA chimeric macromolecules |
| 05/02/2002 | EP1200462A2 Use of quinic, shikimic acids and their derivatives for preparing mannose receptor ligands |
| 05/02/2002 | EP1200460A1 Pseudomycin n-acyl side-chain analogs |
| 05/02/2002 | EP0593585B1 Peptide which abrogates tnf and lps toxicity |
| 05/02/2002 | CA2457111A1 Vaccine for treating allergy |
| 05/02/2002 | CA2427070A1 Preferred segments of neural thread protein and methods of using the same |
| 05/02/2002 | CA2427005A1 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 05/02/2002 | CA2426736A1 Vegf peptides and their use for inhibiting angiogenesis |
| 05/01/2002 | CN1347421A Antifungal agents isolated from pseudomonas syringae |
| 04/30/2002 | US6380376 Purity polypeptides |
| 04/30/2002 | US6380356 Multivalent polymyxin antibiotics |
| 04/30/2002 | US6380162 Ice inhibiting peptides |
| 04/30/2002 | US6380156 Having antiviral, antitumor, and immunosuppressive activities |
| 04/30/2002 | US6379965 Nucleic acid noncovalently associated with a polyamine compound that is covalently attached to an endosome disrupting agent such as cholic acid; nonviral vectors |
| 04/30/2002 | US6379905 Fragments of prion proteins |
| 04/30/2002 | US6379901 Detecting cancer cells that express a human leukocyte antigen molecule using a nonapeptide derived from the tumor rejection antigen precursor; mixing cells and nonapeptide to form complexes; expose to cytolytic cells and determine lysis |
| 04/30/2002 | US6379895 Photolithographic and other means for manufacturing arrays |
| 04/30/2002 | CA2071908C Antibody antagonists of human interleukin-4 |
| 04/30/2002 | CA2054111C Novel inhibitory peptides |
| 04/25/2002 | WO2002032934A1 Antisense peptides to human fc receptors and their uses |
| 04/25/2002 | WO2002032933A1 Endothelin antagonist |
| 04/25/2002 | WO2002032932A2 Urotensin-ii agonists and antagonists |
| 04/25/2002 | WO2002032291A2 Imaging of enzymatic activity |
| 04/25/2002 | WO2001072831A3 Immunoregulator |
| 04/25/2002 | WO2001072782A3 Immuno-reactive peptide CTL epitopes of human cytomegalovirus |
| 04/25/2002 | US20020049301 For therapy of cancer, diabetes, obesity, diseases of the central nervous system, inflammatory disorders, autoimmune dieseases cardiovascular diseases, for generating antibodies |
| 04/25/2002 | US20020049162 Methods for inhibiting smooth muscle cell proliferation |
| 04/25/2002 | US20020049153 Modified peptides capable of forming covalent bonds with one or more blood components, especially albumin, to form a conjugate; administered to treat humans with diabetes |
| 04/25/2002 | DE10050873A1 New metal-binding proteins isolated from cereal seedling extracts, useful for removing and recovering heavy metals from fluid media |
| 04/25/2002 | DE10050091A1 New casein-derived peptide with growth promoting activity, useful as additive for eukaryotic cell cultures and for recombinant protein production |
| 04/25/2002 | CA2425873A1 Imaging of enzymatic activity |
| 04/25/2002 | CA2425804A1 Urotensin-ii agonists and antagonists |
| 04/24/2002 | EP1199361A2 Glycoprotein hormone receptor molecules. Their uses |
| 04/24/2002 | EP1198473A1 Pseudomycin amide and ester analogs |
| 04/24/2002 | EP1198472A1 Amine-modified pseudomycin compounds |
| 04/24/2002 | EP1198471A1 Process for deacylation of lipodepsipeptides |
| 04/24/2002 | EP1198470A1 Pseudomycin prodrugs |
| 04/24/2002 | EP1198256A1 Peptide-lipid conjugates, liposomes and liposomal drug delivery |
| 04/24/2002 | CN1346371A Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases |
| 04/24/2002 | CN1346344A Substituted 2-aminobenzamide caspase ihibitors and the use thereof |
| 04/24/2002 | CN1346279A Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies |
| 04/23/2002 | US6376464 That form amphipathic helices, bind lipids, form prebeta-like or hdl-like complexes, activate lcat, increase serum levels of hdl fractions, and promote cholesterol efflux, dyslipopro-teinemia, hypercholesterolemia, cardiovascular disorders |
| 04/23/2002 | US6376248 Peptide-enhanced transfections |
| 04/23/2002 | US6376207 Assay and reagents for quantifying hBNp |